InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Oneill Alison, Directeur Médical. Director active across 1 company, notably Surface Oncology, Inc.. In total, 5 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €14k. Activity tracked since 1 March 2020. The latest transaction was disclosed on 1 August 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Alison O'Neill is the Chief Medical Officer at Surface Oncology, Inc. She is responsible for leading the company's medical initiatives and clinical research. Alison plays a vital role in developing innovative treatments and improving patient outcomes. Her medical expertise and leadership are crucial for advancing Surface Oncology's mission.